GAO Identifies Factors Hampering Development of New Drug Applications
New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts, Full text GAO-07-49, and Highlights, November 17, 2006. “Recent scientific advances have raised expectations that an increasing number of new and innovative drugs would soon be developed to more effectively prevent, treat, and cure serious illnesses. However, industry analysts …